Payment overview · 2025
General Payments
$87,818.28
122 reported records · 18 companies
Healthcare provider profile · identity verified
Jeromy Brink, MD
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · PHOENIX, AZ · NPI 1003876269
Verified facts
What the public records show
CMS Open Payments records show Jeromy Brink, MD received $87,818.28 in general payments during 2025 across 122 reported records.
Bolton Medical Inc accounted for 71.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 27 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Bolton Medical Inc | Unresolved — no canonical attribution shown | $62,634.72 | 71.3% | 72 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $24,085.51 | 27.4% | 11 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $310.26 | 0.3% | 8 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $195.23 | 0.2% | 7 | 2025 |
| Endologix LLC | Unresolved — no canonical attribution shown | $148.56 | 0.2% | 4 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $72.36 | 0.1% | 3 | 2025 |
| LeMaitre Vascular, Inc. | Unresolved — no canonical attribution shown | $69.72 | 0.1% | 4 | 2025 |
| Okami Medical, Inc. | Unresolved — no canonical attribution shown | $38.27 | 0.0% | 1 | 2025 |
| Reflow Medical Inc | Unresolved — no canonical attribution shown | $37.58 | 0.0% | 2 | 2025 |
| AtriCure, Inc. | Unresolved — no canonical attribution shown | $35.94 | 0.0% | 1 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $34.95 | 0.0% | 2 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $31.92 | 0.0% | 1 | 2025 |
| Kerecis Limited | Unresolved — no canonical attribution shown | $23.68 | 0.0% | 1 | 2025 |
| Baxter Healthcare | Unresolved — no canonical attribution shown | $23.35 | 0.0% | 1 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $22.72 | 0.0% | 1 | 2025 |
| Becton, Dickinson and Company | Unresolved — no canonical attribution shown | $21.86 | 0.0% | 1 | 2025 |
| InspireMD Ltd | Unresolved — no canonical attribution shown | $16.76 | 0.0% | 1 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $14.89 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $53,750.00 | 21 |
| Long term medical supply or device loan | $23,833.33 | 1 |
| Travel and Lodging | $5,697.30 | 19 |
| Food and Beverage | $4,537.65 | 81 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TREO ABDOMINAL STENT-GRAFT SYSTEM Normalized: treo abdominal stent graft system |
Device | Bolton Medical Inc | $51,387.20 | 44 | 2025 |
Source payment records
|
|||||
| AURYON LASER SYSTEM 100-120 VAC Normalized: auryon laser system 100 120 vac |
Device | AngioDynamics, Inc. | $24,085.51 | 11 | 2025 |
Source payment records
|
|||||
| RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Normalized: relay thoracic stent graft with plus delivery system |
Device | Bolton Medical Inc | $6,977.81 | 18 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN VBX Balloon Expandable Endo Normalized: gore viabahn vbx balloon expandable endo |
Device | W. L. Gore & Associates, Inc. | $200.26 | 3 | 2025 |
Source payment records
|
|||||
| AZUR CX DETACHABLE Normalized: azur cx detachable |
Device | Terumo Medical Corporation | $195.23 | 7 | 2025 |
Source payment records
|
|||||
| THORAFLEX HYBRID Normalized: thoraflex hybrid |
Device | Bolton Medical Inc | $159.81 | 1 | 2025 |
Source payment records
|
|||||
| ENDOCROSS Device Normalized: endocross device |
Device | Endologix LLC | $148.56 | 4 | 2025 |
Source payment records
|
|||||
| Torus Stent Graft System Normalized: torus stent graft system |
Device | Endologix LLC | $148.56 | 4 | 2025 |
Source payment records
|
|||||
| RotarexS 6 F x 135 cm Normalized: rotarexs 6 f x 135 cm |
Device | Bard Peripheral Vascular, Inc., Becton, Dickinson and Company | $94.22 | 4 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc., Stryker Corporation | $54.64 | 2 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc., Stryker Corporation | $54.64 | 2 | 2025 |
Source payment records
|
|||||
| RESTOREFLOW Normalized: restoreflow |
Device | LeMaitre Vascular, Inc. | $51.69 | 3 | 2025 |
Source payment records
|
|||||
| GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Normalized: gore excluder thoracoabdominal branch endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $44.07 | 2 | 2025 |
Source payment records
|
|||||
| LOBO Normalized: lobo |
Device | Okami Medical, Inc. | $38.27 | 1 | 2025 |
Source payment records
|
|||||
| ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM Normalized: atricure cryoice cryosphere cryoablation system |
Device | AtriCure, Inc. | $35.94 | 1 | 2025 |
Source payment records
|
|||||
| VIABAHN Endoprosthesis with PROPATEN Bioactive Surface Normalized: viabahn endoprosthesis with propaten bioactive surface |
Device | W. L. Gore & Associates, Inc. | $34.18 | 1 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN Endoprosthesis with Heparin Normalized: gore viabahn endoprosthesis with heparin |
Device | W. L. Gore & Associates, Inc. | $31.75 | 2 | 2025 |
Source payment records
|
|||||
| Kerecis GraftGuide Normalized: kerecis graftguide |
Device | Kerecis Limited | $23.68 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis SurgiClose Normalized: kerecis surgiclose |
Device | Kerecis Limited | $23.68 | 1 | 2025 |
Source payment records
|
|||||
| PREVELEAK Normalized: preveleak |
Device | Baxter Healthcare | $23.35 | 1 | 2025 |
Source payment records
|
|||||
| ZENITH SPIRAL-Z Normalized: zenith spiral z |
Device | Cook Medical LLC | $21.46 | 1 | 2025 |
Source payment records
|
|||||
| HYDRO LEMAITRE VALVULOTOME Normalized: hydro lemaitre valvulotome |
Device | LeMaitre Vascular, Inc. | $18.03 | 1 | 2025 |
Source payment records
|
|||||
| CGuard Prime Carotid Stent System Normalized: cguard prime carotid stent system |
Device | InspireMD Ltd | $16.76 | 1 | 2025 |
Source payment records
|
|||||
| "ACTICOAT 4"" X 4""" Normalized: acticoat 4 x 4 |
Device | Smith+Nephew, Inc. | $14.89 | 1 | 2025 |
Source payment records
|
|||||
| PICO 7 Normalized: pico 7 |
Device | Smith+Nephew, Inc. | $14.89 | 1 | 2025 |
Source payment records
|
|||||
| Pico 14 Normalized: pico 14 |
Device | Smith+Nephew, Inc. | $14.89 | 1 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $13.49 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Clopidogrel | Clopidogrel Bisulfate | 89 | 38 |
| Eliquis | Apixaban | 47 | 13 |
| Gabapentin | Gabapentin | 21 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 17 | 14 |
| Cilostazol | Cilostazol | 16 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $87,818.28 · 122 records | Bolton Medical Inc | "ACTICOAT 4"" X 4""", ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM, AURYON LASER SYSTEM 100-120 VAC, AZUR CX DETACHABLE, CGuard Prime Carotid Stent System, CT THROMBECTOMY SYSTEM KIT, ENDOCROSS Device, FLOWTRIEVER CATHETER, S, GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis, GORE VIABAHN Endoprosthesis with Heparin, GORE VIABAHN VBX Balloon Expandable Endo, HYDRO LEMAITRE VALVULOTOME, Kerecis GraftGuide, Kerecis SurgiClose, LOBO, PICO 7, PREVELEAK, Pico 14, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, RESTOREFLOW, RotarexS 6 F x 135 cm, THORAFLEX HYBRID, TREO ABDOMINAL STENT-GRAFT SYSTEM, Torus Stent Graft System, VIABAHN Endoprosthesis with PROPATEN Bioactive Surface, ZENITH SPIRAL-Z, ZILVER PTX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error